Company / Gross Margin
Co-Diagnostics, Inc. Gross Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
64.3%
FY2025
5-year range
38.6% / 88.2%
FY2021-FY2025
Trend
-13.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 9 years, ranging from 38.6% in FY2023 to 96.1% in FY2018.
Based on SEC 10-K filings.
64.3% in FY2025 with a 5-year CAGR of +16.6%.
Improved from 38.6% to 64.3% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -23.9pp
- 5-Year Change
- +16.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 13.7% year-over-year.
- Peak gross margin was recorded in FY2018.
- Lowest gross margin in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 64.3% | -13.7% |
| FY2024 | 74.5% | +93.1% |
| FY2023 | 38.6% | -56.3% |
| FY2022 | 88.2% | +13.4% |
| FY2021 | 77.8% | +63.0% |
| FY2020 | 47.7% | -37.6% |
| FY2019 | 76.5% | -20.4% |
| FY2018 | 96.1% | +0.0% |
| FY2017 | 96.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026